Phase 1 clinical trial for therapeutic intervention particles (tips).
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110875
- Recipient
-
Institute For Evolvable Medicines UEI W9DGN9JRK8R8
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $4,499,999
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Originally
- Place of performance
- San Francisco, CA 94158, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $1,920,342 | |
| Amendment | -$1,920,342 | |
| Amendment | $0 | |
| Original award | $4,499,999 |
Quick answers
Who received award W81XWH2110875?
W81XWH2110875 was awarded to Institute For Evolvable Medicines by Defense Health Agency (Department of Defense) on September 30, 2021.
How much is award W81XWH2110875 worth?
$4,499,999 has been obligated on W81XWH2110875.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award